Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 42469 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0085] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), located within the 

Department of Health and Human 

Services (HHS), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on July 

19, 2022, from 10:00 a.m. to 3:00 p.m., 

EDT (times subject to change). The 

meeting will be webcast live via the 

World Wide Web. Written comments 

must be received on or before July 26, 

2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0085, by either of the following 

methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027, Attn: July 19, 2022, ACIP 

Meeting. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to https://www.regulations.gov, 

including any personal information 

provided. For access to the docket to 

read background documents or 

comments received, go to https://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, Mailstop H24–8, Atlanta, Georgia 

30329–4027; Telephone: (404) 639– 

8367; Email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 41 CFR 102–3.150(b), 

less than 15 calendar days’ notice is 

being given for this meeting due to the 

exceptional circumstances of the 

COVID–19 pandemic and rapidly 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. A notice 

of this Advisory Committee on 

Immunization Practices (ACIP) meeting 

has also been posted on CDC’s ACIP 

website at: https://www.cdc.gov/ 

vaccines/acip/index.html. In addition, 

CDC has sent notice of this ACIP 

meeting by email to those who subscribe 

to receive email updates about ACIP. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the CDC Director and 

appear on CDC immunization schedules 

must be covered by applicable health 

plans. 

Matters To Be Considered: The agenda 

will include discussions on the use of 

COVID–19 adult vaccines. A 

recommendation vote(s) is scheduled. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. The meeting will be webcast 

live via the World Wide Web; for more 

information on ACIP, visit the ACIP 

website: https://www.cdc.gov/vaccines/ 

acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on July 15, 2022. Written 

comments must be received on or before 

July 26, 2022. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the July 19, 2022, 

ACIP meeting must submit a request at 

https://www.cdc.gov/vaccines/acip/ 

meetings/index.html no later than 11:59 

p.m., EDT, July 15, 2022, according to 

the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals by 

email on July 18, 2022 regarding their 

request to speak. To accommodate the 

significant interest in participation in 

the oral public comment session of 

ACIP meetings, each speaker will be 

limited to three minutes, and each 

speaker may speak only once per 

meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–15225 Filed 7–13–22; 11:15 am] 

BILLING CODE 4163–18–P 


jspears on DSK121TN23PROD with NOTICES1